1 | dialysis | 4,973 |
2 | hemodialysis | 3,506 |
3 | haemodialysis | 638 |
4 | dialytic | 40 |
5 | vaginoplasty | 19 |
6 | post-fontan | 16 |
7 | dialyser | 14 |
8 | montevideo | 13 |
9 | cvhd | 10 |
10 | preservcyt | 10 |
11 | an69st® | 9 |
12 | cf-lvad | 8 |
13 | indecainide | 8 |
14 | waste-to-energy | 8 |
15 | folfox2 | 7 |
16 | maxillectomy | 7 |
17 | 37/39 | 6 |
18 | arseniasis | 6 |
19 | c-train | 6 |
20 | co-enrolment | 6 |
21 | enteric-drained | 6 |
22 | inrplus | 6 |
23 | laryngomicrosurgery | 6 |
24 | oab/ui | 6 |
25 | toxbase | 6 |
26 | uroschesis | 6 |
27 | 30/43 | 5 |
28 | methadone-treated | 5 |
29 | neck-pain | 5 |
30 | shiftworkers | 5 |
31 | 2hours | 4 |
32 | 5760 | 4 |
33 | 6092 | 4 |
34 | azt/3tc/lpv-r | 4 |
35 | epi/epi/epi | 4 |
36 | moulage | 4 |
37 | pca/epi/epi | 4 |
38 | pca/ga/pca | 4 |
39 | porotic | 4 |
40 | roda | 4 |
41 | 2,381 | 3 |
42 | 3,505 | 3 |
43 | 36/88 | 3 |
44 | 5,010 | 3 |
45 | anastrozole/placebo | 3 |
46 | cit-hd | 3 |
47 | cryonics | 3 |
48 | current/voltage | 3 |
49 | dd-treated | 3 |
50 | gh+ox/pl | 3 |
51 | gp-referred | 3 |
52 | methadone-maintenance | 3 |
53 | non-anxiety | 3 |
54 | onbs | 3 |
55 | pca/epi/pca | 3 |
56 | t-cell-depleted | 3 |
57 | xclose | 3 |
58 | 13,764 | 2 |
59 | 23-h/day | 2 |
60 | 31,140 | 2 |
61 | 3437 | 2 |
62 | 4942 | 2 |
63 | 5*10 | 2 |
64 | 5105 | 2 |
65 | 7,917 | 2 |
66 | 7133 | 2 |
67 | 7656 | 2 |
68 | 8,442 | 2 |
69 | 8265 | 2 |
70 | care-treated | 2 |
71 | dandong | 2 |
72 | dysmorphopathic | 2 |
73 | eslope | 2 |
74 | firm-blinded | 2 |
75 | fx80 | 2 |
76 | galvano-forming | 2 |
77 | hsbf6 | 2 |
78 | mid-2014 | 2 |
79 | mild-oxidative-stress-induced | 2 |
80 | non-lpbc | 2 |
81 | noncyanotic | 2 |
82 | post-ebrt | 2 |
83 | pregnancy.the | 2 |
84 | trimer-forming | 2 |
85 | verum-acupuncture | 2 |
86 | ~65,000 | 2 |
87 | 1,150,200 | 1 |
88 | 1,777,035 | 1 |
89 | 1.5-hours | 1 |
90 | 10,808 | 1 |
91 | 12,734 | 1 |
92 | 14,704 | 1 |
93 | 15519 | 1 |
94 | 19,889 | 1 |
95 | 2,2'-azobis-2-amidinopropane | 1 |
96 | 2,328 | 1 |
97 | 2-clips | 1 |
98 | 20,399 | 1 |
99 | 2009.these | 1 |
100 | 209/251 | 1 |
101 | 21,967 | 1 |
102 | 227,451 | 1 |
103 | 29,034 | 1 |
104 | 3,433 | 1 |
105 | 3,953 | 1 |
106 | 30-minute-long | 1 |
107 | 338/412 | 1 |
108 | 342/7932 | 1 |
109 | 38.7±5.6 | 1 |
110 | 39.8±6.8 | 1 |
111 | 3d/four-dimensional | 1 |
112 | 4,593 | 1 |
113 | 4,899 | 1 |
114 | 4,930 | 1 |
115 | 4-fluoro-3-nitrophenyl | 1 |
116 | 4-nitroquinoline-1-oxide | 1 |
117 | 415nm | 1 |
118 | 44,032 | 1 |
119 | 44841 | 1 |
120 | 4767 | 1 |
121 | 498,998 | 1 |
122 | 5,597 | 1 |
123 | 51,351 | 1 |
124 | 56,429 | 1 |
125 | 563,281 | 1 |
126 | 5741 | 1 |
127 | 5943 | 1 |
128 | 60-minute-long | 1 |
129 | 7,964 | 1 |
130 | 7812 | 1 |
131 | 81,819 | 1 |
132 | 85/116 | 1 |
133 | 8q12.3 | 1 |
134 | 9287 | 1 |
135 | abacavir+lamivudine+non-nucleoside-reverse-transciptase-inhibitor | 1 |
136 | acrylamide-biomacromolecule | 1 |
137 | agio₃ | 1 |
138 | alcohol-by-volume | 1 |
139 | anastrozole/goserelin | 1 |
140 | angiotensin-convertingenzyme | 1 |
141 | apolipoproteinb48 | 1 |
142 | attentino | 1 |
143 | azt/lamivudine | 1 |
144 | bsep-mediated | 1 |
145 | btonchitis | 1 |
146 | bullusa | 1 |
147 | calcineurin-inhibitors | 1 |
148 | cattell-horn-carroll | 1 |
149 | cd4-only | 1 |
150 | chemoradiationtherapy | 1 |
151 | chromium-benzenedicarboxylates | 1 |
152 | cmm-vp | 1 |
153 | collagen-glycosaminoglycan | 1 |
154 | copalite | 1 |
155 | coronary-care | 1 |
156 | coumadin® | 1 |
157 | d16 | 1 |
158 | darker-skinned | 1 |
159 | dialysis.hemodialysis | 1 |
160 | dichloromethane-methanol | 1 |
161 | diethylinitrosamine | 1 |
162 | diffusion-edited | 1 |
163 | dimethylnitrosamine- | 1 |
164 | dofetilide-chf | 1 |
165 | dofetilide-mi | 1 |
166 | dose-gained | 1 |
167 | dr-matched | 1 |
168 | e-/cs | 1 |
169 | e-n'- | 1 |
170 | early-art | 1 |
171 | egd-110 | 1 |
172 | electrogastrograms | 1 |
173 | ethanol-consuming | 1 |
174 | event-days | 1 |
175 | exercise-induced-muscle-damage | 1 |
176 | feldkamp | 1 |
177 | ferremia | 1 |
178 | fluid-directed | 1 |
179 | freshly-prepared | 1 |
180 | fw-538 | 1 |
181 | gggtgggtgggtggg | 1 |
182 | glymepiride | 1 |
183 | haemodialysis.twenty-three | 1 |
184 | hepatitis-coinfected | 1 |
185 | heptakis- | 1 |
186 | high-gluten | 1 |
187 | hipercholesterolemic | 1 |
188 | hr-o | 1 |
189 | igm-id | 1 |
190 | imaging/staging | 1 |
191 | incontinence-oab | 1 |
192 | ipt/placebo | 1 |
193 | iwgsc_css_3b_scaff | 1 |
194 | ketamine-anesthetized | 1 |
195 | l747 | 1 |
196 | later-in-treatment | 1 |
197 | ld30 | 1 |
198 | lipegfilgrastim-treated | 1 |
199 | logarithm-natural | 1 |
200 | long-fed | 1 |
201 | macrophage/cell | 1 |
202 | map/environment | 1 |
203 | mental-rotation | 1 |
204 | micro-pattering | 1 |
205 | microfoam-treated | 1 |
206 | mini-vidas | 1 |
207 | ms+cm | 1 |
208 | myeloablative-conditioning | 1 |
209 | n-ethyl-n'-nitro-n-nitroguanidine | 1 |
210 | n-ethyl-n'-nitro-n-nitrosoguanidine | 1 |
211 | nevaripine | 1 |
212 | non-dyskinetic | 1 |
213 | octakis- | 1 |
214 | palmitate- | 1 |
215 | patch-treated | 1 |
216 | pbd3 | 1 |
217 | period.this | 1 |
218 | phase.there | 1 |
219 | phytoseiids | 1 |
220 | pills/mm | 1 |
221 | pmo12o40 | 1 |
222 | pnd4 | 1 |
223 | poly-phosphate | 1 |
224 | polyviologen | 1 |
225 | post-weight-reduction | 1 |
226 | programmmes | 1 |
227 | progression-free- | 1 |
228 | pt-mn/γ-al | 1 |
229 | pt/ti/sio2/si | 1 |
230 | real-rtms | 1 |
231 | rebands | 1 |
232 | refloat | 1 |
233 | renal-failure | 1 |
234 | repeated-jump | 1 |
235 | rituximab® | 1 |
236 | sd-ldl-cholesterol | 1 |
237 | self-processes | 1 |
238 | serine-16 | 1 |
239 | simplex-lattice | 1 |
240 | so2-ethanol-water | 1 |
241 | spe-lc-dad-ltq-linear-ms | 1 |
242 | standard-rat-basic-diet | 1 |
243 | starvin | 1 |
244 | steps-per-day | 1 |
245 | streptozo-tocin | 1 |
246 | tamoxifen/goserelin | 1 |
247 | tbmncu | 1 |
248 | therapies.in | 1 |
249 | therapy-one | 1 |
250 | ti-24nb-4zr-8sn | 1 |
251 | tiloron | 1 |
252 | tiotrochodilation | 1 |
253 | titania/poly | 1 |
254 | training/control | 1 |
255 | tsayeast | 1 |
256 | vas-risk | 1 |
257 | vhl-null | 1 |
258 | washing/ascitic | 1 |
259 | website.135 | 1 |
260 | weekends/holidays | 1 |
261 | wf-100 | 1 |
262 | zidovudine/didanosine/nevirapine | 1 |
263 | zidovudine/lamivudine/delavirdine | 1 |
264 | α-naphthylisothiocyanate | 1 |
1 | 1,150,200 | 1 |
2 | 1,777,035 | 1 |
3 | 1.5-hours | 1 |
4 | 10,808 | 1 |
5 | 12,734 | 1 |
6 | 13,764 | 2 |
7 | 14,704 | 1 |
8 | 15519 | 1 |
9 | 19,889 | 1 |
10 | 2,2'-azobis-2-amidinopropane | 1 |
11 | 2,328 | 1 |
12 | 2,381 | 3 |
13 | 2-clips | 1 |
14 | 20,399 | 1 |
15 | 2009.these | 1 |
16 | 209/251 | 1 |
17 | 21,967 | 1 |
18 | 227,451 | 1 |
19 | 23-h/day | 2 |
20 | 29,034 | 1 |
21 | 2hours | 4 |
22 | 3,433 | 1 |
23 | 3,505 | 3 |
24 | 3,953 | 1 |
25 | 30-minute-long | 1 |
26 | 30/43 | 5 |
27 | 31,140 | 2 |
28 | 338/412 | 1 |
29 | 342/7932 | 1 |
30 | 3437 | 2 |
31 | 36/88 | 3 |
32 | 37/39 | 6 |
33 | 38.7±5.6 | 1 |
34 | 39.8±6.8 | 1 |
35 | 3d/four-dimensional | 1 |
36 | 4,593 | 1 |
37 | 4,899 | 1 |
38 | 4,930 | 1 |
39 | 4-fluoro-3-nitrophenyl | 1 |
40 | 4-nitroquinoline-1-oxide | 1 |
41 | 415nm | 1 |
42 | 44,032 | 1 |
43 | 44841 | 1 |
44 | 4767 | 1 |
45 | 4942 | 2 |
46 | 498,998 | 1 |
47 | 5*10 | 2 |
48 | 5,010 | 3 |
49 | 5,597 | 1 |
50 | 51,351 | 1 |
51 | 5105 | 2 |
52 | 56,429 | 1 |
53 | 563,281 | 1 |
54 | 5741 | 1 |
55 | 5760 | 4 |
56 | 5943 | 1 |
57 | 60-minute-long | 1 |
58 | 6092 | 4 |
59 | 7,917 | 2 |
60 | 7,964 | 1 |
61 | 7133 | 2 |
62 | 7656 | 2 |
63 | 7812 | 1 |
64 | 8,442 | 2 |
65 | 81,819 | 1 |
66 | 8265 | 2 |
67 | 85/116 | 1 |
68 | 8q12.3 | 1 |
69 | 9287 | 1 |
70 | abacavir+lamivudine+non-nucleoside-reverse-transciptase-inhibitor | 1 |
71 | acrylamide-biomacromolecule | 1 |
72 | agio₃ | 1 |
73 | alcohol-by-volume | 1 |
74 | an69st® | 9 |
75 | anastrozole/goserelin | 1 |
76 | anastrozole/placebo | 3 |
77 | angiotensin-convertingenzyme | 1 |
78 | apolipoproteinb48 | 1 |
79 | arseniasis | 6 |
80 | attentino | 1 |
81 | azt/3tc/lpv-r | 4 |
82 | azt/lamivudine | 1 |
83 | bsep-mediated | 1 |
84 | btonchitis | 1 |
85 | bullusa | 1 |
86 | c-train | 6 |
87 | calcineurin-inhibitors | 1 |
88 | care-treated | 2 |
89 | cattell-horn-carroll | 1 |
90 | cd4-only | 1 |
91 | cf-lvad | 8 |
92 | chemoradiationtherapy | 1 |
93 | chromium-benzenedicarboxylates | 1 |
94 | cit-hd | 3 |
95 | cmm-vp | 1 |
96 | co-enrolment | 6 |
97 | collagen-glycosaminoglycan | 1 |
98 | copalite | 1 |
99 | coronary-care | 1 |
100 | coumadin® | 1 |
101 | cryonics | 3 |
102 | current/voltage | 3 |
103 | cvhd | 10 |
104 | d16 | 1 |
105 | dandong | 2 |
106 | darker-skinned | 1 |
107 | dd-treated | 3 |
108 | dialyser | 14 |
109 | dialysis | 4,973 |
110 | dialysis.hemodialysis | 1 |
111 | dialytic | 40 |
112 | dichloromethane-methanol | 1 |
113 | diethylinitrosamine | 1 |
114 | diffusion-edited | 1 |
115 | dimethylnitrosamine- | 1 |
116 | dofetilide-chf | 1 |
117 | dofetilide-mi | 1 |
118 | dose-gained | 1 |
119 | dr-matched | 1 |
120 | dysmorphopathic | 2 |
121 | e-/cs | 1 |
122 | e-n'- | 1 |
123 | early-art | 1 |
124 | egd-110 | 1 |
125 | electrogastrograms | 1 |
126 | enteric-drained | 6 |
127 | epi/epi/epi | 4 |
128 | eslope | 2 |
129 | ethanol-consuming | 1 |
130 | event-days | 1 |
131 | exercise-induced-muscle-damage | 1 |
132 | feldkamp | 1 |
133 | ferremia | 1 |
134 | firm-blinded | 2 |
135 | fluid-directed | 1 |
136 | folfox2 | 7 |
137 | freshly-prepared | 1 |
138 | fw-538 | 1 |
139 | fx80 | 2 |
140 | galvano-forming | 2 |
141 | gggtgggtgggtggg | 1 |
142 | gh+ox/pl | 3 |
143 | glymepiride | 1 |
144 | gp-referred | 3 |
145 | haemodialysis | 638 |
146 | haemodialysis.twenty-three | 1 |
147 | hemodialysis | 3,506 |
148 | hepatitis-coinfected | 1 |
149 | heptakis- | 1 |
150 | high-gluten | 1 |
151 | hipercholesterolemic | 1 |
152 | hr-o | 1 |
153 | hsbf6 | 2 |
154 | igm-id | 1 |
155 | imaging/staging | 1 |
156 | incontinence-oab | 1 |
157 | indecainide | 8 |
158 | inrplus | 6 |
159 | ipt/placebo | 1 |
160 | iwgsc_css_3b_scaff | 1 |
161 | ketamine-anesthetized | 1 |
162 | l747 | 1 |
163 | laryngomicrosurgery | 6 |
164 | later-in-treatment | 1 |
165 | ld30 | 1 |
166 | lipegfilgrastim-treated | 1 |
167 | logarithm-natural | 1 |
168 | long-fed | 1 |
169 | macrophage/cell | 1 |
170 | map/environment | 1 |
171 | maxillectomy | 7 |
172 | mental-rotation | 1 |
173 | methadone-maintenance | 3 |
174 | methadone-treated | 5 |
175 | micro-pattering | 1 |
176 | microfoam-treated | 1 |
177 | mid-2014 | 2 |
178 | mild-oxidative-stress-induced | 2 |
179 | mini-vidas | 1 |
180 | montevideo | 13 |
181 | moulage | 4 |
182 | ms+cm | 1 |
183 | myeloablative-conditioning | 1 |
184 | n-ethyl-n'-nitro-n-nitroguanidine | 1 |
185 | n-ethyl-n'-nitro-n-nitrosoguanidine | 1 |
186 | neck-pain | 5 |
187 | nevaripine | 1 |
188 | non-anxiety | 3 |
189 | non-dyskinetic | 1 |
190 | non-lpbc | 2 |
191 | noncyanotic | 2 |
192 | oab/ui | 6 |
193 | octakis- | 1 |
194 | onbs | 3 |
195 | palmitate- | 1 |
196 | patch-treated | 1 |
197 | pbd3 | 1 |
198 | pca/epi/epi | 4 |
199 | pca/epi/pca | 3 |
200 | pca/ga/pca | 4 |
201 | period.this | 1 |
202 | phase.there | 1 |
203 | phytoseiids | 1 |
204 | pills/mm | 1 |
205 | pmo12o40 | 1 |
206 | pnd4 | 1 |
207 | poly-phosphate | 1 |
208 | polyviologen | 1 |
209 | porotic | 4 |
210 | post-ebrt | 2 |
211 | post-fontan | 16 |
212 | post-weight-reduction | 1 |
213 | pregnancy.the | 2 |
214 | preservcyt | 10 |
215 | programmmes | 1 |
216 | progression-free- | 1 |
217 | pt-mn/γ-al | 1 |
218 | pt/ti/sio2/si | 1 |
219 | real-rtms | 1 |
220 | rebands | 1 |
221 | refloat | 1 |
222 | renal-failure | 1 |
223 | repeated-jump | 1 |
224 | rituximab® | 1 |
225 | roda | 4 |
226 | sd-ldl-cholesterol | 1 |
227 | self-processes | 1 |
228 | serine-16 | 1 |
229 | shiftworkers | 5 |
230 | simplex-lattice | 1 |
231 | so2-ethanol-water | 1 |
232 | spe-lc-dad-ltq-linear-ms | 1 |
233 | standard-rat-basic-diet | 1 |
234 | starvin | 1 |
235 | steps-per-day | 1 |
236 | streptozo-tocin | 1 |
237 | t-cell-depleted | 3 |
238 | tamoxifen/goserelin | 1 |
239 | tbmncu | 1 |
240 | therapies.in | 1 |
241 | therapy-one | 1 |
242 | ti-24nb-4zr-8sn | 1 |
243 | tiloron | 1 |
244 | tiotrochodilation | 1 |
245 | titania/poly | 1 |
246 | toxbase | 6 |
247 | training/control | 1 |
248 | trimer-forming | 2 |
249 | tsayeast | 1 |
250 | uroschesis | 6 |
251 | vaginoplasty | 19 |
252 | vas-risk | 1 |
253 | verum-acupuncture | 2 |
254 | vhl-null | 1 |
255 | washing/ascitic | 1 |
256 | waste-to-energy | 8 |
257 | website.135 | 1 |
258 | weekends/holidays | 1 |
259 | wf-100 | 1 |
260 | xclose | 3 |
261 | zidovudine/didanosine/nevirapine | 1 |
262 | zidovudine/lamivudine/delavirdine | 1 |
263 | ~65,000 | 2 |
264 | α-naphthylisothiocyanate | 1 |
1 | e-n'- | 1 |
2 | progression-free- | 1 |
3 | dimethylnitrosamine- | 1 |
4 | palmitate- | 1 |
5 | octakis- | 1 |
6 | heptakis- | 1 |
7 | ~65,000 | 2 |
8 | wf-100 | 1 |
9 | 1,150,200 | 1 |
10 | 5*10 | 2 |
11 | 5,010 | 3 |
12 | egd-110 | 1 |
13 | 4,930 | 1 |
14 | ld30 | 1 |
15 | 31,140 | 2 |
16 | pmo12o40 | 1 |
17 | 5760 | 4 |
18 | fx80 | 2 |
19 | 5741 | 1 |
20 | 44841 | 1 |
21 | 209/251 | 1 |
22 | 51,351 | 1 |
23 | 227,451 | 1 |
24 | 563,281 | 1 |
25 | 2,381 | 3 |
26 | 338/412 | 1 |
27 | 7812 | 1 |
28 | 44,032 | 1 |
29 | 342/7932 | 1 |
30 | 8,442 | 2 |
31 | 4942 | 2 |
32 | 6092 | 4 |
33 | folfox2 | 7 |
34 | 8q12.3 | 1 |
35 | 7133 | 2 |
36 | 3,433 | 1 |
37 | 30/43 | 5 |
38 | 5943 | 1 |
39 | 3,953 | 1 |
40 | 4,593 | 1 |
41 | pbd3 | 1 |
42 | 14,704 | 1 |
43 | mid-2014 | 2 |
44 | 29,034 | 1 |
45 | 12,734 | 1 |
46 | 13,764 | 2 |
47 | 7,964 | 1 |
48 | pnd4 | 1 |
49 | 5105 | 2 |
50 | 3,505 | 3 |
51 | 1,777,035 | 1 |
52 | website.135 | 1 |
53 | 8265 | 2 |
54 | 38.7±5.6 | 1 |
55 | serine-16 | 1 |
56 | 85/116 | 1 |
57 | d16 | 1 |
58 | 7656 | 2 |
59 | hsbf6 | 2 |
60 | 7,917 | 2 |
61 | 3437 | 2 |
62 | l747 | 1 |
63 | 4767 | 1 |
64 | 21,967 | 1 |
65 | 9287 | 1 |
66 | 5,597 | 1 |
67 | 39.8±6.8 | 1 |
68 | 10,808 | 1 |
69 | 2,328 | 1 |
70 | fw-538 | 1 |
71 | apolipoproteinb48 | 1 |
72 | 36/88 | 3 |
73 | 498,998 | 1 |
74 | 15519 | 1 |
75 | 81,819 | 1 |
76 | 56,429 | 1 |
77 | 37/39 | 6 |
78 | 19,889 | 1 |
79 | 20,399 | 1 |
80 | 4,899 | 1 |
81 | pca/ga/pca | 4 |
82 | pca/epi/pca | 3 |
83 | roda | 4 |
84 | ferremia | 1 |
85 | bullusa | 1 |
86 | incontinence-oab | 1 |
87 | non-lpbc | 2 |
88 | dysmorphopathic | 2 |
89 | hipercholesterolemic | 1 |
90 | non-dyskinetic | 1 |
91 | washing/ascitic | 1 |
92 | noncyanotic | 2 |
93 | porotic | 4 |
94 | dialytic | 40 |
95 | cf-lvad | 8 |
96 | mild-oxidative-stress-induced | 2 |
97 | firm-blinded | 2 |
98 | long-fed | 1 |
99 | dr-matched | 1 |
100 | dose-gained | 1 |
101 | enteric-drained | 6 |
102 | darker-skinned | 1 |
103 | freshly-prepared | 1 |
104 | gp-referred | 3 |
105 | dd-treated | 3 |
106 | methadone-treated | 5 |
107 | care-treated | 2 |
108 | patch-treated | 1 |
109 | microfoam-treated | 1 |
110 | lipegfilgrastim-treated | 1 |
111 | bsep-mediated | 1 |
112 | hepatitis-coinfected | 1 |
113 | fluid-directed | 1 |
114 | t-cell-depleted | 3 |
115 | diffusion-edited | 1 |
116 | ketamine-anesthetized | 1 |
117 | cit-hd | 3 |
118 | cvhd | 10 |
119 | igm-id | 1 |
120 | simplex-lattice | 1 |
121 | methadone-maintenance | 3 |
122 | indecainide | 8 |
123 | glymepiride | 1 |
124 | 4-nitroquinoline-1-oxide | 1 |
125 | haemodialysis.twenty-three | 1 |
126 | moulage | 4 |
127 | exercise-induced-muscle-damage | 1 |
128 | current/voltage | 3 |
129 | pregnancy.the | 2 |
130 | acrylamide-biomacromolecule | 1 |
131 | alcohol-by-volume | 1 |
132 | angiotensin-convertingenzyme | 1 |
133 | 2,2'-azobis-2-amidinopropane | 1 |
134 | n-ethyl-n'-nitro-n-nitroguanidine | 1 |
135 | n-ethyl-n'-nitro-n-nitrosoguanidine | 1 |
136 | zidovudine/lamivudine/delavirdine | 1 |
137 | azt/lamivudine | 1 |
138 | diethylinitrosamine | 1 |
139 | zidovudine/didanosine/nevirapine | 1 |
140 | nevaripine | 1 |
141 | therapy-one | 1 |
142 | eslope | 2 |
143 | coronary-care | 1 |
144 | phase.there | 1 |
145 | renal-failure | 1 |
146 | verum-acupuncture | 2 |
147 | toxbase | 6 |
148 | 2009.these | 1 |
149 | xclose | 3 |
150 | poly-phosphate | 1 |
151 | α-naphthylisothiocyanate | 1 |
152 | copalite | 1 |
153 | iwgsc_css_3b_scaff | 1 |
154 | dofetilide-chf | 1 |
155 | gggtgggtgggtggg | 1 |
156 | imaging/staging | 1 |
157 | galvano-forming | 2 |
158 | trimer-forming | 2 |
159 | ethanol-consuming | 1 |
160 | myeloablative-conditioning | 1 |
161 | micro-pattering | 1 |
162 | dandong | 2 |
163 | 30-minute-long | 1 |
164 | 60-minute-long | 1 |
165 | dofetilide-mi | 1 |
166 | pca/epi/epi | 4 |
167 | epi/epi/epi | 4 |
168 | pt/ti/sio2/si | 1 |
169 | oab/ui | 6 |
170 | vas-risk | 1 |
171 | pt-mn/γ-al | 1 |
172 | 3d/four-dimensional | 1 |
173 | logarithm-natural | 1 |
174 | macrophage/cell | 1 |
175 | cattell-horn-carroll | 1 |
176 | vhl-null | 1 |
177 | dichloromethane-methanol | 1 |
178 | sd-ldl-cholesterol | 1 |
179 | training/control | 1 |
180 | gh+ox/pl | 3 |
181 | 4-fluoro-3-nitrophenyl | 1 |
182 | ms+cm | 1 |
183 | pills/mm | 1 |
184 | 415nm | 1 |
185 | collagen-glycosaminoglycan | 1 |
186 | post-fontan | 16 |
187 | polyviologen | 1 |
188 | high-gluten | 1 |
189 | therapies.in | 1 |
190 | neck-pain | 5 |
191 | c-train | 6 |
192 | streptozo-tocin | 1 |
193 | anastrozole/goserelin | 1 |
194 | tamoxifen/goserelin | 1 |
195 | starvin | 1 |
196 | tiotrochodilation | 1 |
197 | mental-rotation | 1 |
198 | post-weight-reduction | 1 |
199 | tiloron | 1 |
200 | ti-24nb-4zr-8sn | 1 |
201 | hr-o | 1 |
202 | anastrozole/placebo | 3 |
203 | ipt/placebo | 1 |
204 | montevideo | 13 |
205 | attentino | 1 |
206 | feldkamp | 1 |
207 | repeated-jump | 1 |
208 | cmm-vp | 1 |
209 | azt/3tc/lpv-r | 4 |
210 | dialyser | 14 |
211 | so2-ethanol-water | 1 |
212 | abacavir+lamivudine+non-nucleoside-reverse-transciptase-inhibitor | 1 |
213 | mini-vidas | 1 |
214 | onbs | 3 |
215 | e-/cs | 1 |
216 | cryonics | 3 |
217 | phytoseiids | 1 |
218 | rebands | 1 |
219 | programmmes | 1 |
220 | self-processes | 1 |
221 | chromium-benzenedicarboxylates | 1 |
222 | period.this | 1 |
223 | arseniasis | 6 |
224 | uroschesis | 6 |
225 | dialysis | 4,973 |
226 | haemodialysis | 638 |
227 | hemodialysis | 3,506 |
228 | dialysis.hemodialysis | 1 |
229 | btonchitis | 1 |
230 | spe-lc-dad-ltq-linear-ms | 1 |
231 | electrogastrograms | 1 |
232 | real-rtms | 1 |
233 | 2-clips | 1 |
234 | shiftworkers | 5 |
235 | calcineurin-inhibitors | 1 |
236 | 1.5-hours | 1 |
237 | 2hours | 4 |
238 | inrplus | 6 |
239 | event-days | 1 |
240 | weekends/holidays | 1 |
241 | refloat | 1 |
242 | standard-rat-basic-diet | 1 |
243 | co-enrolment | 6 |
244 | map/environment | 1 |
245 | later-in-treatment | 1 |
246 | early-art | 1 |
247 | post-ebrt | 2 |
248 | tsayeast | 1 |
249 | preservcyt | 10 |
250 | tbmncu | 1 |
251 | steps-per-day | 1 |
252 | 23-h/day | 2 |
253 | waste-to-energy | 8 |
254 | cd4-only | 1 |
255 | titania/poly | 1 |
256 | maxillectomy | 7 |
257 | chemoradiationtherapy | 1 |
258 | laryngomicrosurgery | 6 |
259 | non-anxiety | 3 |
260 | vaginoplasty | 19 |
261 | agio₃ | 1 |
262 | rituximab® | 1 |
263 | coumadin® | 1 |
264 | an69st® | 9 |